NCT03289195View on ClinicalTrials.gov

Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Breast Cancer
Interventions
PROCEDURE

MRI Biopsy

Patient will undergo percutaneous MR guided biopsy by study Breast Radiologist within 0-60 days of completing NAC.

Trial Locations (7)

10065

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

10604

Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison

11570

Memorial Sloan Kettering Nassau (All Protocol Activities), Rockville Centre

11725

Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack

07920

Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge

07748

Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown

07645

Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT03289195 - Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer | Biotech Hunter | Biotech Hunter